Related Experiment Video
Updated: Aug 2, 2026

08:36
Functional Neuroimaging Using Ultrasonic Blood-brain Barrier Disruption and Manganese-enhanced MRI
Published on: July 12, 2012
Barbiturate potentiation in mercury poisoning
Bulletin of Environmental Contamination and Toxicology
|June 11, 1975
Summary
Japanese quail exposed to methylmercury showed increased barbiturate potentiation (BP), indicating early mercury toxicity. Selenium supplementation prevented this effect, suggesting mercury
Area of Science:
- Environmental toxicology
- Neuropharmacology
Background:
- Methylmercury is a neurotoxicant with a long biological half-life.
- Assessing early toxic effects of methylmercury is crucial for understanding its impact on wildlife and potentially humans.
Purpose of the Study:
- To investigate the effects of dietary methylmercury on Japanese quail.
- To determine if barbiturate potentiation (BP) can serve as an early indicator of methylmercury toxicity.
- To evaluate the protective role of selenium against methylmercury-induced BP.
Main Methods:
- Japanese quail were fed diets containing methylmercuric chloride at various concentrations (4, 21, 24 ppm).
- Barbiturate potentiation (BP) was measured as an indicator of neurological response.
- Selenium was administered to assess its protective effects.
Main Results:
- Dietary methylmercury exposure led to a dose-dependent increase in barbiturate potentiation (BP).
- Gross symptoms of mercury poisoning appeared later than the observed BP.
- BP remained elevated for 7 weeks after mercury withdrawal, indicating mercury's long biological half-life.
- Selenium effectively prevented BP after 7 days of exposure to toxic methylmercury levels.
Conclusions:
- Barbiturate potentiation (BP) is a sensitive early indicator of methylmercury toxicity in Japanese quail.
- Methylmercury exposure may alter drug activity and increase nervous system sensitivity to barbiturates.
- Selenium demonstrates a protective effect against methylmercury-induced neurotoxicity.
Related Concept Videos
Anticholinesterase Agents: Poisoning and Treatment
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
CNS Depressants: Barbiturates and Benzodiazepines
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
Sedatives and Hypnotics Drugs: Barbiturates
Sedatives and hypnotics encompass a drug class that acts on the central nervous system (CNS) to alleviate anxiety, promote relaxation and induce sleep.These drugs function by amplifying the actions of the neurotransmitter γ-aminobutyric acid (GABA), resulting in reduced neuronal activity. Barbiturates, a subset of sedatives and hypnotics first synthesized in the late 1800s, are categorized into ultra-short, short, intermediate, and long-acting groups based on their duration of effect. A key...
Antiepileptic Drugs: GABAergic Pathway Potentiators
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
Drug Toxicity: Dose-Dependent Reactions
Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Pharmaceutical Poisoning: Treatment Strategies
Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...

